Abstract
Congenital disorders of glycosylation (CDG) are a variable, rapidly expanding group of genetic metabolic disorders. Glycosylation is fundamental to the processing of proteins and lipids, and as such, disorders in these pathways can cause multisystemic effects. Symptoms can be evident as early as the prenatal period and should be suspected in an infant with multisystemic disease. Biochemical screening and confirmatory molecular genetic tests are available; however, their sensitivity is imperfect and some patients are now being diagnosed by whole exome sequencing. Early diagnosis is important, because treatment options are available for some subtypes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.